Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.47
HUM's Cash to Debt is ranked lower than
72% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.61 vs. HUM: 0.47 )
Ranked among companies with meaningful Cash to Debt only.
HUM' s 10-Year Cash to Debt Range
Min: 0.26  Med: 0.80 Max: N/A
Current: 0.47
Equity to Asset 0.39
HUM's Equity to Asset is ranked higher than
56% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.39 vs. HUM: 0.39 )
Ranked among companies with meaningful Equity to Asset only.
HUM' s 10-Year Equity to Asset Range
Min: 0.25  Med: 0.37 Max: 0.55
Current: 0.39
0.25
0.55
Interest Coverage 11.30
HUM's Interest Coverage is ranked lower than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.26 vs. HUM: 11.30 )
Ranked among companies with meaningful Interest Coverage only.
HUM' s 10-Year Interest Coverage Range
Min: 4.98  Med: 13.40 Max: 20.5
Current: 11.3
4.98
20.5
F-Score: 4
WACC vs ROIC
9.50%
31.44%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 4.40
HUM's Operating margin (%) is ranked higher than
62% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.70 vs. HUM: 4.40 )
Ranked among companies with meaningful Operating margin (%) only.
HUM' s 10-Year Operating margin (%) Range
Min: -3.64  Med: 3.43 Max: 6.07
Current: 4.4
-3.64
6.07
Net-margin (%) 2.39
HUM's Net-margin (%) is ranked higher than
66% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.51 vs. HUM: 2.39 )
Ranked among companies with meaningful Net-margin (%) only.
HUM' s 10-Year Net-margin (%) Range
Min: -3.74  Med: 2.20 Max: 4.04
Current: 2.39
-3.74
4.04
ROE (%) 12.20
HUM's ROE (%) is ranked higher than
65% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.50 vs. HUM: 12.20 )
Ranked among companies with meaningful ROE (%) only.
HUM' s 10-Year ROE (%) Range
Min: -25.87  Med: 13.52 Max: 23.54
Current: 12.2
-25.87
23.54
ROA (%) 5.08
HUM's ROA (%) is ranked higher than
76% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.05 vs. HUM: 5.08 )
Ranked among companies with meaningful ROA (%) only.
HUM' s 10-Year ROA (%) Range
Min: -7.32  Med: 4.99 Max: 8.39
Current: 5.08
-7.32
8.39
ROC (Joel Greenblatt) (%) 185.32
HUM's ROC (Joel Greenblatt) (%) is ranked higher than
67% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 86.39 vs. HUM: 185.32 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HUM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -87.3  Med: 159.13 Max: 271.45
Current: 185.32
-87.3
271.45
Revenue Growth (3Y)(%) 12.30
HUM's Revenue Growth (3Y)(%) is ranked lower than
54% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.30 vs. HUM: 12.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HUM' s 10-Year Revenue Growth (3Y)(%) Range
Min: 1.1  Med: 9.90 Max: 27.3
Current: 12.3
1.1
27.3
EBITDA Growth (3Y)(%) 4.60
HUM's EBITDA Growth (3Y)(%) is ranked lower than
70% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. HUM: 4.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HUM' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -9.5  Med: 15.70 Max: 38.5
Current: 4.6
-9.5
38.5
EPS Growth (3Y)(%) -4.50
HUM's EPS Growth (3Y)(%) is ranked lower than
75% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.40 vs. HUM: -4.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HUM' s 10-Year EPS Growth (3Y)(%) Range
Min: -19.9  Med: 27.40 Max: 41.9
Current: -4.5
-19.9
41.9
» HUM's 10-Y Financials

Financials


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

HUM Guru Trades in Q2 2014

Stanley Druckenmiller 83,900 sh (New)
Lee Ainslie 771,168 sh (New)
Paul Tudor Jones 8,191 sh (+63.82%)
Pioneer Investments 824,411 sh (+17.61%)
David Dreman 2,544 sh (+16.16%)
Jeremy Grantham 1,024,957 sh (+13.31%)
Mario Gabelli 5,000 sh (unchged)
Jim Simons Sold Out
HOTCHKIS & WILEY 3,391,273 sh (-0.73%)
Larry Robbins 5,016,176 sh (-2.26%)
Vanguard Health Care Fund 5,698,794 sh (-8.48%)
Joel Greenblatt 5,647 sh (-27.61%)
John Hussman 50,000 sh (-50.00%)
» More
Q3 2014

HUM Guru Trades in Q3 2014

Ray Dalio 9,311 sh (New)
Steve Mandel 2,174,122 sh (New)
Andreas Halvorsen 493,602 sh (New)
Paul Tudor Jones 15,970 sh (+94.97%)
Jeremy Grantham 1,125,953 sh (+9.85%)
Joel Greenblatt 5,973 sh (+5.77%)
Larry Robbins 5,016,536 sh (+0.01%)
Pioneer Investments 752,240 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
John Hussman 50,000 sh (unchged)
Stanley Druckenmiller Sold Out
Lee Ainslie Sold Out
David Dreman Sold Out
Vanguard Health Care Fund 5,247,894 sh (-7.91%)
HOTCHKIS & WILEY 3,079,572 sh (-9.19%)
» More
Q4 2014

HUM Guru Trades in Q4 2014

Louis Moore Bacon 50,000 sh (New)
First Eagle Investment 453,653 sh (New)
Steven Cohen 51,500 sh (New)
Andreas Halvorsen 658,313 sh (+33.37%)
Joel Greenblatt 6,252 sh (+4.67%)
Vanguard Health Care Fund 5,247,894 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
Jeremy Grantham 1,106,954 sh (-1.69%)
Ray Dalio 9,011 sh (-3.22%)
Steve Mandel 1,911,536 sh (-12.08%)
Pioneer Investments 599,900 sh (-20.25%)
HOTCHKIS & WILEY 2,366,024 sh (-23.17%)
John Hussman 25,000 sh (-50.00%)
Larry Robbins 2,207,844 sh (-55.99%)
Paul Tudor Jones 4,900 sh (-69.32%)
» More
Q1 2015

HUM Guru Trades in Q1 2015

Leon Cooperman 593,400 sh (New)
Larry Robbins 5,016,536 sh (+127.21%)
Andreas Halvorsen 1,380,231 sh (+109.66%)
Paul Tudor Jones 8,555 sh (+74.59%)
Ray Dalio 12,511 sh (+38.84%)
Pioneer Investments 643,190 sh (+7.22%)
Vanguard Health Care Fund 5,247,894 sh (unchged)
Mario Gabelli 5,000 sh (unchged)
Steve Mandel Sold Out
John Hussman Sold Out
Joel Greenblatt 5,948 sh (-4.86%)
Jeremy Grantham 974,065 sh (-12.00%)
HOTCHKIS & WILEY 1,685,855 sh (-28.75%)
Louis Moore Bacon 34,111 sh (-31.78%)
First Eagle Investment 296,553 sh (-34.63%)
Steven Cohen 31,100 sh (-39.61%)
» More
» Details

Insider Trades

Latest Guru Trades with HUM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Humana Inc

Weekly 52-Week Highs Highlight: HUM, EBAY, SYK, FRCPRD
According to GuruFocus list of 52-week highs, Humana Inc, eBay Inc, Stryker Corporation, and First Republic Bank have all reached their 52-week highs. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 24.08
HUM's P/E(ttm) is ranked higher than
67% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 31.10 vs. HUM: 24.08 )
Ranked among companies with meaningful P/E(ttm) only.
HUM' s 10-Year P/E(ttm) Range
Min: 4.25  Med: 10.82 Max: 34.62
Current: 24.08
4.25
34.62
Forward P/E 19.19
HUM's Forward P/E is ranked lower than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.54 vs. HUM: 19.19 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 25.00
HUM's PE(NRI) is ranked higher than
67% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 31.10 vs. HUM: 25.00 )
Ranked among companies with meaningful PE(NRI) only.
HUM' s 10-Year PE(NRI) Range
Min: 4.26  Med: 10.82 Max: 34.62
Current: 25
4.26
34.62
P/B 2.80
HUM's P/B is ranked higher than
54% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.96 vs. HUM: 2.80 )
Ranked among companies with meaningful P/B only.
HUM' s 10-Year P/B Range
Min: 0.71  Med: 1.77 Max: 3.82
Current: 2.8
0.71
3.82
P/S 0.57
HUM's P/S is ranked higher than
57% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.62 vs. HUM: 0.57 )
Ranked among companies with meaningful P/S only.
HUM' s 10-Year P/S Range
Min: 0.11  Med: 0.38 Max: 0.66
Current: 0.57
0.11
0.66
PFCF 57.34
HUM's PFCF is ranked lower than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 16.86 vs. HUM: 57.34 )
Ranked among companies with meaningful PFCF only.
HUM' s 10-Year PFCF Range
Min: 2.77  Med: 7.41 Max: 65.64
Current: 57.34
2.77
65.64
POCF 27.60
HUM's POCF is ranked lower than
90% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.53 vs. HUM: 27.60 )
Ranked among companies with meaningful POCF only.
HUM' s 10-Year POCF Range
Min: 2.5  Med: 6.24 Max: 31.57
Current: 27.6
2.5
31.57
EV-to-EBIT 9.81
HUM's EV-to-EBIT is ranked higher than
81% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.97 vs. HUM: 9.81 )
Ranked among companies with meaningful EV-to-EBIT only.
HUM' s 10-Year EV-to-EBIT Range
Min: -0.7  Med: 3.50 Max: 15.9
Current: 9.81
-0.7
15.9
PEG 3.01
HUM's PEG is ranked lower than
73% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.77 vs. HUM: 3.01 )
Ranked among companies with meaningful PEG only.
HUM' s 10-Year PEG Range
Min: 0.14  Med: 0.58 Max: 4.35
Current: 3.01
0.14
4.35
Shiller P/E 23.99
HUM's Shiller P/E is ranked higher than
71% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.24 vs. HUM: 23.99 )
Ranked among companies with meaningful Shiller P/E only.
HUM' s 10-Year Shiller P/E Range
Min: 6.36  Med: 15.60 Max: 73.72
Current: 23.99
6.36
73.72
Days Sales Outstanding 12.19
HUM's Days Sales Outstanding is ranked higher than
81% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 24.15 vs. HUM: 12.19 )
Ranked among companies with meaningful Days Sales Outstanding only.
HUM' s 10-Year Days Sales Outstanding Range
Min: 6.84  Med: 10.19 Max: 18.31
Current: 12.19
6.84
18.31

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.60
HUM's Dividend Yield is ranked lower than
91% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.29 vs. HUM: 0.60 )
Ranked among companies with meaningful Dividend Yield only.
HUM' s 10-Year Dividend Yield Range
Min: 0.3  Med: 0.99 Max: 1.61
Current: 0.6
0.3
1.61
Dividend Payout 0.14
HUM's Dividend Payout is ranked higher than
80% of the 10 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.25 vs. HUM: 0.14 )
Ranked among companies with meaningful Dividend Payout only.
HUM' s 10-Year Dividend Payout Range
Min: 0.09  Med: 0.12 Max: 0.3
Current: 0.14
0.09
0.3
Dividend growth (3y) 14.00
HUM's Dividend growth (3y) is ranked lower than
88% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 29.10 vs. HUM: 14.00 )
Ranked among companies with meaningful Dividend growth (3y) only.
HUM' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 14
Current: 14
0
14
Yield on cost (5-Year) 0.60
HUM's Yield on cost (5-Year) is ranked lower than
92% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.68 vs. HUM: 0.60 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
HUM' s 10-Year Yield on cost (5-Year) Range
Min: 0.3  Med: 0.99 Max: 1.61
Current: 0.6
0.3
1.61
Share Buyback Rate 2.40
HUM's Share Buyback Rate is ranked higher than
73% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.60 vs. HUM: 2.40 )
Ranked among companies with meaningful Share Buyback Rate only.
HUM' s 10-Year Share Buyback Rate Range
Min: 2.4  Med: -0.10 Max: -1.4
Current: 2.4

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 4.12
HUM's Price/Tangible Book is ranked higher than
67% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.13 vs. HUM: 4.12 )
Ranked among companies with meaningful Price/Tangible Book only.
HUM' s 10-Year Price/Tangible Book Range
Min: 1.36  Med: 2.97 Max: 12.28
Current: 4.12
1.36
12.28
Price/Projected FCF 1.06
HUM's Price/Projected FCF is ranked lower than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.08 vs. HUM: 1.06 )
Ranked among companies with meaningful Price/Projected FCF only.
HUM' s 10-Year Price/Projected FCF Range
Min: 0.3  Med: 0.68 Max: 2.18
Current: 1.06
0.3
2.18
Price/DCF (Earnings Based) 1.07
HUM's Price/DCF (Earnings Based) is ranked higher than
89% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.30 vs. HUM: 1.07 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.51
HUM's Price/Median PS Value is ranked lower than
96% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.18 vs. HUM: 1.51 )
Ranked among companies with meaningful Price/Median PS Value only.
HUM' s 10-Year Price/Median PS Value Range
Min: 0.21  Med: 0.85 Max: 2.6
Current: 1.51
0.21
2.6
Price/Peter Lynch Fair Value 3.80
HUM's Price/Peter Lynch Fair Value is ranked lower than
100% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.83 vs. HUM: 3.80 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HUM' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.23  Med: 0.65 Max: 4.46
Current: 3.8
0.23
4.46
Price/Graham Number 2.06
HUM's Price/Graham Number is ranked higher than
82% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.84 vs. HUM: 2.06 )
Ranked among companies with meaningful Price/Graham Number only.
HUM' s 10-Year Price/Graham Number Range
Min: 0.65  Med: 1.41 Max: 6.64
Current: 2.06
0.65
6.64
Earnings Yield (Greenblatt) (%) 10.73
HUM's Earnings Yield (Greenblatt) (%) is ranked higher than
86% of the 28 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.40 vs. HUM: 10.73 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HUM' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 6.3  Med: 28.10 Max: 3813.4
Current: 10.73
6.3
3813.4
Forward Rate of Return (Yacktman) (%) 10.60
HUM's Forward Rate of Return (Yacktman) (%) is ranked lower than
76% of the 17 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.01 vs. HUM: 10.60 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HUM' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 2.3  Med: 27.90 Max: 54
Current: 10.6
2.3
54

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, WLP, AET, CI » details
Traded in other countries:HUM.Germany,
Humana Inc was organized as a Delaware corporation in 1964. The Company is a health care company that offers insurance products and health and wellness services. Its segments include Retail, Employer Group, and Healthcare Services. These segments are based on a combination of the type of health plan customer and adjacent businesses centered on integrated care delivery for its health plans and other customers. The Retail segment consists of Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products, marketed directly to individuals, and includes its contract with Centers for Medicare and Medicaid Services, or CMS, to administer the LI-NET prescription drug plan program, and contracts with various states to provide Medicaid, dual eligible, and Long-Term Support Services benefits, collectively its state-based contracts. The Employer Group segment consists of Medicare and commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary benefit products, as well as administrative services only products, or ASO, and its health and wellness products marketed to employer groups. The Healthcare Services segment includes services offered to its health plan members as well as to third parties, including pharmacy, provider services, home based services, integrated behavioral health services, and predictive modeling and informatics services. The Other Businesses category consists of its military services. Its TRICARE South Region contract, Puerto Rico Medicaid, and closed-block long-term care insurance policies. The Company's competitors vary by local market and include other managed care companies, national insurance companies, and other HMOs and PPOs, including HMOs and PPOs owned by Blue Cross/Blue Shield plans.
» More Articles for HUM

Headlines

Articles On GuruFocus.com
Weekly 52-Week Highs Highlight: HUM, EBAY, SYK, FRCPRD Jun 02 2015 
Hotchkis & Wiley Large Cap Value Fund Q1 2015 Commentary May 22 2015 
Humana Inc. Posts Mixed Set Of Numbers In Q1 Of FY2015 May 05 2015 
Humana And Concentra To Part Ways Mar 27 2015 
Humana Inc. Might Become The Acquisition Target In The Medicare Segment Mar 22 2015 
Undervalued Stocks in Steve Mandel's Portfolio Feb 18 2015 
Top 4 Undervalued stocks in Hotchkis & Wiley’s Portfolio Feb 16 2015 
UNH: A Strong Candidate for Income and Capital Appreciation Dec 12 2014 
Facebook Among New Holdings in Steve Mandel's Portfolio Nov 20 2014 
Add Humana for a Healthier Portfolio Oct 10 2014 

More From Other Websites
Insurers choose partners, and dance floor shrinks Jul 04 2015
Rivals Lurked Behind Aetna's Deal With Humana Jul 03 2015
Aetna to buy Humana as health insurer landscape shifts Jul 03 2015
Aetna to buy Humana as health insurer landscape shifts Jul 03 2015
Aetna to buy Humana for $37bn in cash and shares Jul 03 2015
Humana & Aetna: Finally Jul 03 2015
Aetna’s Humana deal to bring scrutiny on other insurer tie-ups - experts Jul 03 2015
Aetna's Humana deal to bring scrutiny on other insurer tie-ups -experts Jul 03 2015
Trending Now: Humana Jul 03 2015
Aetna, Humana CEOs say deal bolsters Medicare, Medicaid businesses Jul 03 2015
Aetna-Humana Merger Marks Sway of Health-Care Law Jul 03 2015
Hedge Funds Were Right About Humana Inc (HUM) Jul 03 2015
Aetna to Acquire Humana for $37 Billion, Combined Entity to Drive Consumer-Focused, High-Value... Jul 03 2015
Seven interesting things Humana is telling employees and stakeholders Jul 03 2015
Aetna to Buy Humana in $35 Billion Deal to Expand in Medicare Jul 03 2015
Aetna to Buy Humana for $37 Billion in Cash and Stock Jul 03 2015
Aetna to buy Humana for $37 billion in largest insurance deal Jul 03 2015
Aetna to buy Humana for $37 bln in largest insurance deal Jul 03 2015
Aetna to buy Humana for $37 bln in largest insurance deal Jul 03 2015
Aetna buys Humana for $37B amid record number of health care deals Jul 03 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK